Reuters
What moved and what’s next. We report the move. We do not invent the reason for it. Prices are delayed.
Reuters
Reuters
Reuters
Reuters
Reuters
CNBC
Reuters
CNBC
What each kind of story does to a valuation.
Reuters
What an energy story does to a valuation: Energy prices sit in the cost line of most industrials and in the revenue line of producers, so the same move tends to push the two in opposite directions.
Reuters
No reviewed explanation for this kind of story, so we offer none.
What a rates story does to a valuation: Rates feed straight into a discounted cash flow: a higher discount rate lowers what any future stream of cash is worth today, and the effect is largest for companies whose profits sit furthest out.
What an energy story does to a valuation: Energy prices sit in the cost line of most industrials and in the revenue line of producers, so the same move tends to push the two in opposite directions.
What a trade story does to a valuation: A tariff is a cost that has to land somewhere — on the importer's margin or on the customer's price — and which of the two absorbs it is what decides whether it shows up in a company's margins or in its volumes.
No reviewed explanation for this kind of story, so we offer none.
Explained 4 of 6. Newest story dated .
ReutersWording: unclear
ReutersWording: negative
ReutersWording: unclear
ReutersWording: unclear
ReutersWording: unclear
CNBCWording: unclear
ReutersWording: negative
CNBCWording: unclear
ReutersWording: unclear
ReutersWording: unclear
ReutersWording: unclear
CNBCWording: unclear
CNBCWording: negative
ReutersWording: unclear
ReutersWording: negative
ReutersWording: unclear
CNBCWording: unclear
ReutersWording: unclear
ReutersWording: positive
ReutersWording: unclear
CNBCWording: unclear
ReutersWording: unclear
ReutersWording: unclear
ReutersWording: unclear
US futures are little changed pre-open (+0.2%)
Futures are where the US market is indicated to open versus yesterday's close. The VIX (‘fear gauge’) is 14.7 — calm, -1.0% overnight.
Prices are delayed. The brief did not say when these prices were taken.
On the horizon
Last close-to-close move. Snapshot from · Prices are delayed.
Across all US-listed companies above $2B — the whole market, not a watchlist.
Showing 10 of 40
| Company | Price | Day |
|---|---|---|
| $40.85 |
| up +35.7% |
| BFLYButterfly Network, Inc.Needham Initiates Coverage of Butterfly Network with Buy Rating | $9.93 | up +22.0% |
|---|
| VICRVicor CorporationVicor: VPD Licensing Is A Game Changer | $268.34 | up +19.8% |
|---|
| SGRYSurgery Partners, Inc.Can Intuitive Surgical Make Up For A Lower Price Per Surgery? | $15.80 | up +15.7% |
|---|
| INODInnodata Inc.Cerebras Systems vs. Innodata: Which AI-Driven Tech Stock Is a Better Buy in 2026? | $69.97 | up +14.6% |
|---|
| TNGXTango Therapeutics, Inc.Why Is Tango Therapeutics (TNGX) Down 6.2% Since Last Earnings Report? | $25.53 | up +14.3% |
|---|
| BLLNBillionToOne, Inc.BillionToOne SVP Sells 1,416 Shares | $116.07 | up +11.8% |
|---|
| HYMCHycroft Mining Holding CorporatHycroft Provides Project Update | $22.69 | up +10.5% |
|---|
| IBRXImmunityBio, Inc. | $9.29 | up +9.9% |
|---|
| TTANServiceTitan, Inc. | $61.56 | up +8.9% |
|---|
Showing 10 of 40
| Company | Price | Day |
|---|---|---|
| CLDXCelldex Therapeutics, Inc.Celldex Therapeutics, Inc. (CLDX) Discusses Positive Phase 3 Results for Barzolvolimab in Chronic Spontaneous Urticaria Transcript | $33.51 | down −11.6% |
| PLNTPlanet Fitness, Inc.Planet Fitness Growth Could Be Pressured Amid Rising High Volume, Low Price Competition, Deutsche Bank Says | $42.60 | down −9.5% |
| PLBLPolibeli Group Ltd | $5.80 | down −8.9% |
| NKTRNektar TherapeuticsBTIG Reiterates Buy on Nektar Therapeutics, Maintains $178 Price Target | $60.97 | down −8.8% |
| CARAvis Budget Group, Inc.Morgan Stanley Maintains Equal-Weight on Avis Budget Gr, Lowers Price Target to $95 | $107.73 | down −8.1% |
| LPLALPL Financial Holdings Inc.Former LPL Employee Sues Firm, Alleging Age Discrimination | $307.50 | down −7.5% |
| LFTOLiftoff Mobile, Inc.Piper Sandler Initiates Coverage On Liftoff Mobile with Neutral Rating, Announces Price Target of $19 | $16.35 | down −7.4% |
| NYTNew York Times Company (The)The New York Times Company (NYT) Presents at Citi's 2026 Global TMT Conference Transcript | $65.45 | down −7.2% |
| WGSGeneDx Holdings Corp. | $90.80 | down −7.2% |
| BSPBending Spoons S.p.A. | $36.17 | down −6.8% |